 |
| Research article summary (published 17 Jan 2009): |
[Valproate treatment during pregnancy: description of four cases with foetal valproate syndrome]
(Behandling med valproat under graviditet: beskrivelse af fire cases med føtalt valproatsyndrom.)
Full Abstract
INTRODUCTION: Treatment with valproate is associated with an increased risk of teratogenicity compared to other antiepileptic drugs and can cause a complex of serious symptoms usually referred to as "foetal valproate symdrome" which is characterised by major and minor malformations in association with developmental delay. This paper aims to give attention to the syndrome through four case descriptions. Furthermore, possible risk factors and the use of the mutation 677C-T as a risk marker are discussed. MATERIAL AND METHODS: Nine developmentally retarded children from a parent group, born of mothers who were treated with valproate during pregnancy, were neuropediatrically and neuropsychologically examined in a non-acute setting. The mothers were screened for the 677C-T mutation. RESULTS: Four of seven examined children fulfilled the criteria for foetal valproate syndrome. Only one of the four mothers was heterozygote for the 677C-T mutation (CT, n = 1/4) and none of the mothers were homozygote (TT, n = 0/4) CONCLUSION: The foetal valproate syndrome is a complex of symptoms which is probably underdiagnosed and should be considered in the diagnostic evaluation program for children with developmental delay who are born of mothers with epilepsy. The 677C-T mutation does not seem to be a useful genetic marker of this syndrome.
Author information
Author/s: Sabers, Anne (A); Larsen, Katja (K); Blichfeldt, Susanne (S); Sahlholdt, Lene (L); Rasmussen, John Oskaer (JO);
Affiliation: Epilepsiklinikken, Glostrup Hospital, DK-2600 Glostrup. anns(-atsign-)glo.regionh.dk
Journal and publication information
Publication Type: English Abstract; Journal Article
Journal: Ugeskrift for laeger (Ugeskr Laeger), published in Denmark. (Language: dan)
Reference: 2009-Jan; vol 171 (issue 4) : pp 221-5
Dates: Created 2009/01/28; Completed 2009/02/04; Revised 2009/02/11;
PMID: 19174036, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Common antiepileptic drugs in pregnancy in women with epilepsy.
30 Dec 2003 - Birth defects and epilepsy medication. 30 May 2006
- [Fetal valproate syndrome]
7 Oct 2003 - [Human teratogenicity of valproic acid containing antiepileptic drugs]
17 Dec 1982 - Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. 29 Nov 2002
- The longer term outcome of children born to mothers with epilepsy. 30 Oct 2004
- Teratogenicity of antiepileptic drugs and drug specific malformations. 30 May 1993
- Pregnancy, epilepsy, management and outcome: a 10-year perspective. 29 Nov 1993
- Neurodevelopmental outcomes of children born to mothers with epilepsy. 30 Jan 2004
- Teratogenic effects of antiepileptic drugs: what do we advise patients? 30 Aug 1997
Related Article Map
12/17/1982
5/30/2006
Higher Relevance Score (52)
Lower Relevance Score (40)
Legend: - FREE Full text Article. - Abstract only. - Title only. More help.
See a large map of 100+ related articles.